Correlation Between Moleculin Biotech and Hoth Therapeutics
Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and Hoth Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and Hoth Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moleculin Biotech and Hoth Therapeutics, you can compare the effects of market volatilities on Moleculin Biotech and Hoth Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of Hoth Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and Hoth Therapeutics.
Diversification Opportunities for Moleculin Biotech and Hoth Therapeutics
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Moleculin and Hoth is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech and Hoth Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hoth Therapeutics and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech are associated (or correlated) with Hoth Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hoth Therapeutics has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and Hoth Therapeutics go up and down completely randomly.
Pair Corralation between Moleculin Biotech and Hoth Therapeutics
Given the investment horizon of 90 days Moleculin Biotech is expected to under-perform the Hoth Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Moleculin Biotech is 1.26 times less risky than Hoth Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Hoth Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 123.00 in Hoth Therapeutics on August 27, 2024 and sell it today you would lose (39.00) from holding Hoth Therapeutics or give up 31.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Moleculin Biotech vs. Hoth Therapeutics
Performance |
| Timeline |
| Moleculin Biotech |
| Hoth Therapeutics |
Moleculin Biotech and Hoth Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Moleculin Biotech and Hoth Therapeutics
The main advantage of trading using opposite Moleculin Biotech and Hoth Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, Hoth Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hoth Therapeutics will offset losses from the drop in Hoth Therapeutics' long position.| Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. Bio Path Holdings |
| Hoth Therapeutics vs. Capricor Therapeutics | Hoth Therapeutics vs. Soleno Therapeutics | Hoth Therapeutics vs. Bio Path Holdings | Hoth Therapeutics vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |